ijms-logo

Journal Browser

Journal Browser

Gut Microbiota in Human Diseases and Health

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Microbiology".

Deadline for manuscript submissions: 30 September 2024 | Viewed by 1281

Special Issue Editors


E-Mail Website
Guest Editor
Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia/Infectious Diseases Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Interests: viral infections; treatment; clinical impact; antiviral drugs; clinical picture
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor

Special Issue Information

Dear Colleagues,

Cumulative knowledge has revealed that gut microbiota contributes to the development and progression of different chronic diseases, including Long-COVID-19 Syndrome. Gut dysbiosis can have an impact on multiple organs through several gut‒organ axes. The aim of this Special Issue is to shed a light on knowledge that has been accumulated in the context of gut‒organ axes with a focus on the potential role of gut microbiota composition in the pathogenesis of Long-COVID-19 Syndrome. The authors are encouraged to submit their original research studies concerning this topic. Review articles will also be taken into consideration.

Dr. Raffaele Bruno
Dr. Valentina Zuccaro
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • gut microbiota
  • dysbiosis
  • gut-organ axis
  • Long-COVID-19 Syndrome
  • pathogenesis

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

9 pages, 273 KiB  
Article
A Pilot Interaction Analysis of Gut Microbiota and Peripheral Markers of Aging in Severe Psychiatric Disorders: A Role for Lachnoclostridium?
by Mirko Manchia, Pasquale Paribello, Claudia Pisanu, Donatella Congiu, Athos Antoniades, Paris Vogazianos, Federica Tozzi, Federica Pinna, Aristos Aristodimou, Paola Caria, Tinuccia Dettori, Daniela Virginia Frau, Cristina Cocco, Barbara Noli, Concetta Panebianco, Valerio Pazienza, Bernardo Carpiniello and Alessio Squassina
Int. J. Mol. Sci. 2023, 24(24), 17618; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms242417618 - 18 Dec 2023
Viewed by 931
Abstract
Excessive predominance of pathological species in the gut microbiota could increase the production of inflammatory mediators at the gut level and, via modification of the gut–blood barrier, at the systemic level. This pro-inflammatory state could, in turn, increase biological aging that is generally [...] Read more.
Excessive predominance of pathological species in the gut microbiota could increase the production of inflammatory mediators at the gut level and, via modification of the gut–blood barrier, at the systemic level. This pro-inflammatory state could, in turn, increase biological aging that is generally proxied by telomere shortening. In this study, we present findings from a secondary interaction analysis of gut microbiota, aging, and inflammatory marker data from a cohort of patients with different diagnoses of severe mental disorders. We analyzed 15 controls, 35 patients with schizophrenia (SCZ), and 31 patients with major depressive disorder (MDD) recruited among those attending a community mental health center (50 males and 31 females, mean and median age 46.8 and 46.3 years, respectively). We performed 16S rRNA sequencing as well as measurement of telomere length via quantitative fluorescence in situ hybridization and high-sensitivity C-reactive protein. We applied statistical modeling with logistic regression to test for interaction between gut microbiota and these markers. Our results showed statistically significant interactions between telomere length and gut microbiota pointing to the genus Lachnostridium, which remained significantly associated with a reduced likelihood of MDD even after adjustment for a series of covariates. Although exploratory, these findings show that specific gut microbiota signatures overexpressing Lachnoclostridium and interacting with biological aging could modulate the liability for MDD. Full article
(This article belongs to the Special Issue Gut Microbiota in Human Diseases and Health)
Back to TopTop